tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
EDIT is currently covered by 6 analysts with an average price target of $5.27. This is a potential upside of $3.52 (96.64%) from yesterday's end of day stock price of $2.68.
Editas Medicine's activity chart (see below) currently has 113 price targets and 123 ratings on display. The stock rating distribution of EDIT is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 44.4% with an average time for these price targets to be met of 111.12 days.
Highest price target for EDIT is $8, Lowest price target is $4, average price target is $5.27.
Most recent stock forecast was given by from CHARDAN CAPITAL on 05-May-2026. First documented stock forecast 29-Feb-2016.
Currently out of the existing stock ratings of EDIT, 6 are a BUY (75%), 2 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Apr-2019
$4
$1.15 (40.35%)
$3.5
2 months 23 days ago
(05-May-2026)
2/11 (18.18%)
$0.96 (31.58%)
330
Hold Since 10-Mar-2026
$8
$5.15 (180.70%)
$13
4 months 18 days ago
(10-Mar-2026)
0/2 (0%)
$5.36 (203.03%)
Buy Since 18-Dec-2024
$4.6
$1.75 (61.40%)
$4
8 months 18 days ago
(10-Nov-2025)
1/2 (50%)
$2.08 (82.54%)
294
Buy Since 28-Apr-2025
$5
$2.15 (75.44%)
$5
10 months 23 days ago
(05-Sep-2025)
1/3 (33.33%)
$2.24 (81.16%)
72
Hold Since 13-Dec-2024
$4
$1.15 (40.35%)
10 months 25 days ago
(03-Sep-2025)
3/7 (42.86%)
$1.5 (60.00%)
45
What is EDIT (Editas Medicine) average time for price targets to be met?
Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?
Which analyst has the most public recommendations on EDIT (Editas Medicine)?
Which analyst is the currently most bullish on EDIT (Editas Medicine)?
Which analyst is the currently most reserved on EDIT (Editas Medicine)?
